The Coagulation Twins: The Story That Revealed the Error in the Code
How the study of two twin brothers, one with hemophilia and one without, allowed scientists to find the exact genetic flaw and opened the doors to the treatment revolution.
The Hemophilia Dossier: The Engineering of Coagulation
This dossier is an engineering analysis of hemophilia. We start with the human story of twins who revealed the 'error in the code,' explore recombinant DNA 'bio-factories,' demystify the AAV 'viral carrier' technology, and analyze the future of gene editing with CRISPR.
Recombinant DNA: The 'Bio-Factory' That Brought Hope
The story of how scientists bypassed blood plasma and created the first safe source of Factor VIII, using 'domesticated' cells in the lab.
The 'Viral Postman': The Real Technology Behind Gene Therapy
How a harmless virus, called AAV, was 'domesticated' by science to become the perfect delivery vehicle, carrying the healthy F8 gene copy directly to the liver.
Hemgenix and Luxturna: An Analysis of Multi-Million Dollar Cures
We explore the first approved gene therapy drugs for hemophilia and other diseases. But why do they cost millions? The complexity of innovation versus the ethical and financial dilemma.
The Next Frontier: Where CRISPR's 'Scissors' Enter the Story
CRISPR is not a 'delivery' therapy, but an 'editing' one. Understand what the molecular scissors are, how they promise to correct the F8 gene on-site, and the ethical and safety challenges of this frontier.
